ArticleThe Prostate2023

A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis.

Tyler Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.